Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bio-Rad Laboratories Q1 Adj. EPS $2.54 Beats $1.81 Estimate, Sales $585.40M Beat $573.26M Estimate

Author: Benzinga Newsdesk | May 01, 2025 04:18pm
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.54 per share which beat the analyst consensus estimate of $1.81 by 40.33 percent. This is a 10.92 percent increase over earnings of $2.29 per share from the same period last year. The company reported quarterly sales of $585.40 million which beat the analyst consensus estimate of $573.26 million by 2.12 percent. This is a 4.16 percent decrease over sales of $610.82 million the same period last year.

Posted In: BIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist